usp

Bedford Laboratories today issued updated guidance on the following nationwide voluntary product recalls originally issued on August 2, 2011: Polymyxin B for Injection USP, 500,000 Units per vial – NDC #55390-139-10 Lot 1942980 – Exp.

Date August 2013 and Lot 1895027 – Exp. Date June 2013

American Regent, Inc. is conducting a nationwide voluntary recall of 5 lots of Vasopressin Injection, USP 20 units/mL (200 units/10mL), 10 mL Multiple Dose Vials; 11 lots of Vasopressin Injection, USP 20 units/mL, 1 mL Multiple Dose Vials; and 1 lot of Vasopressin Injection, USP 10 units/0.5 mL,0.5 mL Multiple Dose Vials to the Retail/Hospital level.

Qualitest Pharmaceuticals today issued a voluntary nationwide retail level recall of Butalbital, Acetaminophen, and Caffeine Tablets USP, 50mg/325mg/40mg, and Hydrocodone Bitartrate and Acetaminophen Tablets, USP 7.5mg/500mg.

This recall was initiated because an individual bottle of Butalbital, Acetaminophen, and Caffeine Tablets USP, 50mg/325mg/40mg, 500 count was found incorrectly labeled with a Hydrocodone Bitartrate and Acetaminophen Tablets, USP 7.5mg/500mg, 1000 count label, printed with Lot Number C0590909B.

American Regent is conducting a nationwide voluntary recall to the consumer and user level of the following product: Sterile Water for Injection, USP, 50 mL Single Dose Vial, NDC # 0517-3050-25, Lot 0092, Exp.

Date February, 2014 PLEASE NOTE: This recall, initiated on May 19, 2011 to the User or Consumer Level, is for Lot 0092 Only.

American Regent is conducting a nationwide voluntary recall of the three lots listed below of the following product: Bacteriostatic Sodium Chloride Injection, USP, 0.9%, 30 mL, Multiple Dose Vials NDC # 0517-0648-25

An ABC news affiliate from Illinois has posted some very well considered and concise guidelines for supplement usage that we would like to share with you.